Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an ...
(Bloomberg) -- Eli Lilly & Co. said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results